Assenagon Asset Management S.A. - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 131 filers reported holding OCULAR THERAPEUTIX INC in Q1 2022. The put-call ratio across all filers is 1.09 and the average weighting 0.9%.

Quarter-by-quarter ownership
Assenagon Asset Management S.A. ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q4 2021$95,000
-51.5%
13,694
-30.1%
0.00%
-100.0%
Q3 2021$196,000
-85.8%
19,597
-79.8%
0.00%
-80.0%
Q2 2021$1,376,000
-12.6%
97,014
+1.2%
0.01%
-16.7%
Q1 2021$1,574,000
-20.7%
95,8950.0%0.01%
-33.3%
Q4 2020$1,985,00095,8950.01%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q1 2022
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$31,590100.00%
Opaleye Management Inc. 5,780,000$29,824,8007.13%
DELTEC ASSET MANAGEMENT LLC 1,974,797$10,189,9532.23%
Lynwood Capital Management Inc. 262,500$1,354,5001.72%
Endurant Capital Management LP 368,438$1,901,1401.66%
Knoll Capital Management, LLC 200,000$1,032,0001.25%
Knoll Capital Management, LLC 95,800$814,3000.99%
SECTORAL ASSET MANAGEMENT INC 802,680$4,141,8290.69%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,977$1,553,0410.22%
Cormorant Asset Management, LP 645,000$3,328,2000.19%
View complete list of OCULAR THERAPEUTIX INC shareholders